ARTICLE | Clinical News
Atrisorb tissue regeneration barrier containing doxycycline: ATRX will begin a 120-patient pivotal trial
July 13, 1998 7:00 AM UTC
Atrix Laboratories Inc. (ATRX), Fort Collins, Colo. Product: Atrisorb tissue regeneration barrier containing doxycycline Indication: Treat periodontal disease Status: ATRX will begin a 120-patient pi...